- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06193980
ICU Combined Assessment of Cardio-Respiratory Exercise (ICU-CARE)
Exercise Testing in ICU Survivors to Evaluate ICU-acquired Weakness
Study Overview
Status
Detailed Description
This longitudinal study will assess cardiovascular fitness and microvascular function through two (2) follow-ups after ICU discharge: at (i) 6 months, and (ii) 12 months. The first timepoint will be at 6 months will be required, and the second timepoint at 12 months will be optional based on participant availability. The goal is to understand how microvascular dysfunction contributes to ICU-AW and long-term exercise limitation in ICU survivors.
Specific goals are:
- Determine the feasibility of study enrollment and protocol completion.
- Evaluate peak oxygen uptake and oxygen on/off kinetics in ICU survivors using a standardized cardiopulmonary exercise test (CPET) protocol. This protocol has been adapted from Santana et. al. (2025) for the ICU population.
- Characterize skeletal muscle microvascular function in ICU survivors using high-resolution NIRS during CPET protocol.
- Determine the association between impairments in skeletal muscle microvascular oxygen delivery and cardiovascular blood flow regulation in ICU survivors.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Asher Mendelson, MD PhD
- Phone Number: 204-787-1634
- Email: asher.mendelson@umanitoba.ca
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2H 2A6
- Recruiting
- St. Boniface General Hospital
-
Contact:
- Asher Mendelson, MD PhD
- Phone Number: 204-787-1634
- Email: asher.mendelson@umanitoba.ca
-
Winnipeg, Manitoba, Canada, R3A 1R9
- Recruiting
- Health Sciences Centre Winnipeg
-
Contact:
- Asher Mendelson, MD PhD
- Phone Number: 204-787-1634
- Email: asher.mendelson@umanitoba.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who have received mechanical ventilation for at least 7 days in the intensive care unit (ICU) and have subsequently been discharged from hospital.
Exclusion Criteria:
- Unable to provide consent
- Trajectory of health expected to be significantly limited in the upcoming 12 months
- those who self-report that they cannot climb at least one flight of stairs due to limited exercise capacity
- have significant orthopedic or musculoskeletal impairment affecting mobility
- have a medical history of neuromuscular disease
- ongoing respiratory limitations (i.e., supplemental oxygen)
- significant heart disease (i.e. ejection fraction less than 30%, unstable ischemic heart disease, severe valvular heart disease)
- a body mass index (BMI) of ≥ 40 kg/m2 (impacting NIRS signal due to adipose tissue thickness)
- if participant's primary residence is a significant distance from the participating study site
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
ICU survivors
Patients who have received prolonged mechanical ventilation (7 days or more) in the intensive care unit (ICU), and have been discharged from hospital.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VO2 peak oxygen uptake
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
Peak Oxygen uptake (VO2, mL/kg/min) will be measured during incremental exercise on a cycle ergometer during cardiopulmonary exercise testing (CPET).
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
oxygen on/off kinetics
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
time constant (seconds) of oxygen uptake will be assessed at the transition to constant work rate exercise at the beginning of CPET; time constant (seconds) of oxygen uptake will also be assessed at the transition to rest at the end of CPET after reaching VO2 peak.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
NIRS deoxygenation during exercise (deoxy-hemoglobin)
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
NIRS will be applied to the vastus lateralis during exercise testing.
Deoxygenation profile, as measured by increase in deoxy-hemoglobin will be recorded throughout exercise.
Higher values indicate impaired oxygen delivery to tissue.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
NIRS deoxygenation during exercise (tissue saturation index)
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
NIRS will be applied to the vastus lateralis during exercise testing.
Deoxygenation profile, as measured by decrease in tissue saturation index will be recorded throughout exercise.
Lower values indicate impaired oxygen delivery to tissue.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
Rate of enrollment
Time Frame: 6 months after ICU discharge
|
Rate of participant enrollment in the study will be recorded.
Feasibility of enrollment will be one participant per month.
|
6 months after ICU discharge
|
|
Protocol completion
Time Frame: Ongoing throughout 12 months after ICU discharge
|
The number of completed sessions within 12 months for each eligible patient will be recorded.
Feasibility target will be ≥ 80% completion of the protocol at 6 month time point for all participants.
|
Ongoing throughout 12 months after ICU discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Independence Measure (FIM) Questionnaire
Time Frame: Questionnaire will be conducted on up to 2 (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
will assess functional capacity, and will be administered by research staff.
Response will be sought directly from the patient.
FIM is scored with motor (13-91) and cognitive (5-35).
Lower scores indicate lower functional independence
|
Questionnaire will be conducted on up to 2 (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
Frailty Index
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
The frailty index identifies 42 deficits, each coded as 0 (absent), 1 (present), or 0.5 (where intermediate values were possible).
It was calculated as the cumulative proportion of deficits present (minimum score 0; maximum score 1.0), and then graded as mild (0 and 0.2), moderate (0.2 and 0.4) or severe frailty (>0.4).
See references for studies where Index is derived.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
Medical Research Council (MRC) sum score
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
Medical Research Council (MRC) sum score tests power in muscle groups for upper and lower extremities and score is tallied as the sum of all tested muscles.
Value ranges from complete paralysis (0/60) to full strength (60/60).
Score less than 48/60 denotes clinically significant weakness.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
Anaerobic threshold
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
Work rate at anaerobic threshold (AT), represented at percentage of VO2 peak will be quantified with CPET.
This corresponds to the time where oxygen (O2) utilization and carbon dioxide (CO2) production curves begin to diverge.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
Forced Vital Capacity (FVC)
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
Standard spirometry techniques are used to quantify the maximum volume of expired breath (Litres), and represented as a %predicted compared to reference values.
All tests are performed in accordance with standard ATS guidelines.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
|
Forced Expiratory Volume at 1-second (FEV1)
Time Frame: Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
Standard spirometry techniques are used to quantify the volume of expired breath (Litres) in 1 second, and represented as a %predicted compared to reference values.
All tests are performed in accordance with standard ATS guidelines.
|
Tests will be conducted on up to two (2) different occasions after ICU discharge: (i) 6 months, and (ii) 12 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Asher Mendelson, MD PhD, University of Manitoba
Publications and helpful links
General Publications
- Heyland DK, Garland A, Bagshaw SM, Cook D, Rockwood K, Stelfox HT, Dodek P, Fowler RA, Turgeon AF, Burns K, Muscedere J, Kutsogiannis J, Albert M, Mehta S, Jiang X, Day AG. Recovery after critical illness in patients aged 80 years or older: a multi-center prospective observational cohort study. Intensive Care Med. 2015 Nov;41(11):1911-20. doi: 10.1007/s00134-015-4028-2. Epub 2015 Aug 26.
- Mendelson AA, Erickson D, Villar R. The role of the microcirculation and integrative cardiovascular physiology in the pathogenesis of ICU-acquired weakness. Front Physiol. 2023 May 10;14:1170429. doi: 10.3389/fphys.2023.1170429. eCollection 2023.
- Muscedere J, Bagshaw SM, Boyd G, Sibley S, Norman P, Day A, Hunt M, Rolfson D. The frailty, outcomes, recovery and care steps of critically ill patients (FORECAST) study: pilot study results. Intensive Care Med Exp. 2022 Jun 10;10(1):23. doi: 10.1186/s40635-022-00446-7.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS25592
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States